Key facts
- This page summarizes Joseph Edward Tucker's Form 3 filing for Lakewood-Amedex Biotherapeutics Inc. (LABT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 May 2026, 18:19.
Joseph Edward Tucker - 24 Apr 2026 Form 3 Insider Report for Lakewood-Amedex Biotherapeutics Inc. (LABT)
- Reporting relationship
- Director
- Issuer ticker
- LABT
- Reported as of
- 24 Apr 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 06 May 2026, 18:19:02 UTC
- Prior SEC filing
- 30 Dec 2025
- Next SEC filing
- 03 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/Joseph Tucker
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joseph Edward Tucker filed Form 3 for Lakewood-Amedex Biotherapeutics Inc. (LABT) on 06 May 2026.
Change
- Previous filing in this sequence was filed on 30 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001883914
Primary reporting owner
Tucker Joseph Edward
- Relationship
- Director
- Address
- 8031 COOPER CREEK BLVD UNIT 103, UNIVERSITY PARK
- Signature
- /s/Joseph Tucker
- Signature date
- 06 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LABT
holding
Common Stock; $0.0001 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 24 Apr 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.